PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancer

• Chen Chen,
• Yixin Zhou,
• Xuanye Zhang,
• Shaodong Hong,
• Bei Zhang,
• Liangping Xia,
• Sha Fu,
• Ping Chen,
• Hui Yu,
• Lina He

Affiliations

Chen Chen

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China

Yixin Zhou

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China

Xuanye Zhang

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China

Shaodong Hong

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China

Bei Zhang

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China

Liangping Xia

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China

Sha Fu

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Pathology Department, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China

Ping Chen

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China

Hui Yu

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China

Lina He

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China